NEW YORK – Linear Diagnostics last week announced that it has received a £2 million ($2.6 million) investment.
The UK's Midlands Engine Investment Fund led the round, joined by the UK Innovation Science and Seed Fund, the University of Birmingham, Abingdon Health, and the firm's directors.
Linear Diagnostics, a spinout from the UK's University of Birmingham, plans to use the funds to develop its optical point-of-care diagnostic testing platform.